The 2024 IIER 1781st International Conference on Science, Innovation, and Management (ICSIM) is slated for May 21st to 22nd, 2024, in Washington DC, USA. Sponsored by the International Institute of Engineers and Researchers (IIER), it aims to emerge as a prominent global platform for showcasing groundbreaking advancements in Science, Innovation, and Management. Since its inception in 2014, ICSIM has served as a pivotal international forum for presenting technological breakthroughs and research findings in these domains. By bringing together leading researchers, engineers, and scientists from across the globe, the conference facilitates collaboration and exchange of ideas to enhance techniques related to Science, Innovation, and Management.

Read on theiier.org

The 2024 IIER 1788th International Conference on Recent Advances in Medical Science (ICRAMS) is scheduled to take place in Washington DC, USA, from May 21st to 22nd, 2024. Sponsored by the International Institute of Engineers and Researchers (IIER), it aims to stand out as a premier global conference for showcasing innovative breakthroughs in the realm of Recent Advances in Medical Science. With a history dating back to 2014, ICRAMS provides a vital platform for presenting cutting-edge research and technological advancements in the medical science field. The event facilitates collaboration among researchers and practitioners worldwide, fostering advancements in medical science techniques and methodologies.

Read on theiier.org

As we contemplate this year's event, we eagerly anticipate making Innovations '24 for Healthcare Professionals Education Symposium even more impactful. Save the date - May 21-23, 2024, at the Hilton Orlando, Florida. Join us for the exclusive vendor-run conference featuring specialized best practices, interactive soft skills training, and networking opportunities with like-minded clinical and management professionals.

Read on siemens-healthineers.com

The U.S. Department of Health and Human Services reported 618 breaches affecting 500+ people's health records. The HealthSec Summit USA, scheduled for May 21st - 22nd, 2024 in Boston, will gather industry leaders to discuss IT & OT security, digital transformation in healthcare, and medical technology advancements, fostering insight, strategy, and knowledge exchange.

Read on healthsec.cs4ca.com

Tailored for the pharmaceutical sector, this Summit addresses the critical hurdles in incorporating clinically-validated digital health solutions into traditional pharmaceutical processes. Featuring 100+ senior decision-makers from leading pharma firms, this event promises valuable industry networking and practical insights to apply in your work. Join us for a transformative experience.

Read on evidencebaseddigitalhealth.com

AMIA's Clinical Informatics Conference (CIC) is a pivotal event uniting over 700 clinical informaticists across disciplines. From physicians to technicians, attendees share technology innovations for real-world care delivery. CIC focuses on leveraging technology to advance healthcare delivery, access, and outcomes. Through workshops and presentations, participants gain practical tools to further the quadruple aim, guided by unbiased evidence and experience-based content. Join us to drive healthcare outcomes forward.

Read on amia.org

The ADC Payload Summit, part of the World ADC Series, is scheduled from Tue, 21 May 2024, to Thu, 23 May 2024, addressing the evolving landscape of ADC payloads. With lower potency topoisomerase I inhibitors showing clinical success, developers aim to diversify mechanisms of action and expand disease indications. This unique forum explores altering payload chemistry, novel cytotoxic payloads, and challenges/opportunities of lower potency and non-oncology payloads, providing insights for optimizing ADC efficacy. Joining 60+ peers in Chemistry, Medicinal Chemistry, and Discovery, attendees uncover strategies to enhance traditional payloads and explore novel mechanisms of action for improved ADC performance.

 [Read on adc-payload-summit.com](https://adc-payload-summit.com/take-part/pricing-and-registration-adc-payload-summit/)

The 9th 3D Tissue Models Summit 2024, scheduled from May 21 to May 23, marks a pivotal moment in pharmaceutical innovation. With initiatives like Roche's Institute of Human Biology and MSD's collaboration with Inventia for bioprinting 3D in vitro models, the event underscores the transformative potential of 3D tissue models in drug development. This summit, returning to Boston, offers a platform to explore 23+ real-world applications of complex in vitro models. Attendees will gain insights from frontline experts, enabling them to optimize drug development workflows with confidence and stay at the forefront of this rapidly evolving field. 

[Read on 3d-tissuemodels.com](https://3d-tissuemodels.com/)

The 6th Annual Cell Engager Summit returns, prioritizing back translation from bedside to bench and novel targets. With 7 recent approvals, the field is vibrant, aiming to deliver more life-changing therapies to patients with significant unmet needs. Join industry leaders from JNJ, Astellas, Amgen, and more to explore expanding target spaces and tackling translational challenges in developing cell engager therapies for solid and liquid tumors. Attendees will delve into clinical case studies, engineering improvements, and mitigating cytokine release syndrome, making this summit a vital hub for advancements in T-cell, BiTe's, gamma delta, and NK engagers. 

[Read on cell-engager-summit.com](https://cell-engager-summit.com/)

The 5th Cytokine-Based Drug Development Summit 2024, held from May 21-23, heralds a new phase in cytokine therapies. Leading developers employ cutting-edge technologies and novel targets to surmount efficacy and toxicity hurdles, expanding disease focus. This pivotal industry summit integrates past insights, offering a disease-agnostic perspective. With a curated agenda spanning oncology, autoimmune, and infectious diseases, this 3-day event stands as the singular industry-driven platform for cytokine research. Amidst enhanced translational knowledge and technology, it strives to bring life-changing drugs to patients, emphasizing the reinvigorated potential in the cytokine landscape. 

[Read on cytokine-based-drugdevelopment](https://cytokine-based-drugdevelopment.com/)